Guest lecture by Markus Feuerer | Nonlymphoid-tissue Treg cells and engineered Treg cells
Medical Priority Immunotherapy EventPlesmanlaan 125
1066 CX Amsterdam
The Netherlands
Guest lecture by Prof Markus Feuerer PhD (LIT Leibniz Institut for Immunotherapy University of Regensburg)
Title: Nonlymphoid-tissue Treg cells and engineered Treg cells
Host: Derk Amsen
Dr. Markus Feuerer studied medicine in Mainz and Heidelberg (Germany). He was a postdoctoral research fellow at the German Rheumatism Research Centre and Charité University Clinic, Berlin, (Germany), and at the Joslin Diabetes Center and Harvard Medical School (Boston, USA). After his postdoctoral time, he was head of an independent Helmholtz Young Investigator Group at the German Cancer Research Center (DKFZ) in Heidelberg. He is now head of the Department of Immunology at the newly established Leibniz Institute for Immunotherapy (LIT) in Regensburg, Deputy Scientific Director of the LIT and member of the Management Board of the LIT. In addition, he is a Professor of Immunology and head of the Chair for Immunology at the University of Regensburg.
Research interests:
- Immune regulation, regulatory T cells
- Tissue immunology, tissue-resident immune cell differentiation, tissue-immune communication, wound healing and tissue homeostasis by immune cells
- Immune responses against tumors, transplantation immunology and autoimmunity
- Synthetic immunology, engineered immune cells as “living drugs”